Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalfampridine for post-stroke motor impairment
IRCT20250526065899N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind, single-arm trial of dalfampridine in stroke, sponsored by Islamic Azad University. Primary endpoint: Motor assessment scoring. Started Aug 2026; status: completed.
02
Drugs
dalfampridine
03
Conditions
stroke
Beyond the preview
Go deeper on IRCT20250526065899N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250526065899N1.